NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of CVS Health Corporation (“CVS”) (NYSE: CVS) between May 3, 2023 and April 30, 2024, inclusive (the “Class Period”). For more information, submit a form at CVS Health Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call ...

SAN DIEGO, July 15, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CVS Health Corporation (NYSE: CVS) securities between May 3, 2023 and April 30, 2024, inclusive (the “Class Period”), have until September 10, 2024 to seek appointment as lead plaintiff of the CVS class action lawsuit. Captioned Nixon v. CVS Health Corporation, No. 24-cv-05303 (S.D.N.Y.), the CVS class action lawsuit charges CVS and certain of CVS’s top current and former executives with v ...

NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased securities of CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS) between May 3,2023 and April 30, 2024, inclusive (the “Class Period”). The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading st ...

NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24-cv-05303, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CVS securities between May 3, 2023 and April 30, 2024, bot ...

The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging population, technological advances, and rising healthcare costs provide the sector with a compelling combination of growth potential and resilience. This market sector's vast scale and intrinsic appeal create a lucrative landscape for investors proficient at identifying promising opportunities.Get UnitedHealth Group alerts:U ...

The economy is picking up as we speak. Unemployment currently sits at 3.7%, close to pre-pandemic levels. Interestingly, sectors that faced significant workforce and profitability issues during the pandemic, such as healthcare, are more profitable than pre-pandemic levels. Additionally, jobs eliminated during the pandemic have come back from growth across other business verticals. For instance, the healthcare sector is experiencing job growth with innovations through SaaS verticals with the advent of teleme ...

CVS Health (CVS) , the pharmacy retail and PBM powerhouse, has witnessed a substantial 24% decline over the past three months. In fact, during the last trading session, the stock closed at $56.62, which marked a more than 47% plunge from its 52-week high of $83.25 and was quite close to its 52-week low of $52.77.Not only this, the stock is currently trading below its 50-day and 200-day moving averages, indicating the possibility of a further bearish shift in the stock's price.CVS Below 50 & 200 Day SMAImage ...

WOONSOCKET, R.I., July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 1, 2024, to holders of record on July 22, 2024.CVS Health logo (PRNewsFoto/CVS Health)About CVS HealthCVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the heal ...

WOONSOCKET, R.I., July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7th, 2024, at 8:00 a.m. ET to discuss second quarter 2024 financial results.An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.CVS Health logo (PRNewsFoto/CVS Health)About CVS HealthCVS Health® is the leading health ...

CVS pharmacy and convenience store, building exterior, New York City, New York, USA. (Photo by: ... [+] GHI-Plexi Images/UCG/Universal Images Group via Getty Images)UCG/Universal Images Group via Getty ImagesCVS Health stock (NYSE: CVS) currently trades at $58 per share, 47% below its pre-inflation shock high of $110 seen in February 2022. In contrast, its peer – Walgreens stock – is down 75% over this period, amid falling profitability. CVS stock was trading at $93 in early June 2022, just before the Fed s ...